Corbus Pharmaceuticals (NASDAQ:CRBP) just reported results for the second quarter of 2024.
- Corbus Pharmaceuticals reported earnings per share of -90 cents. This was above the analyst estimate for EPS of -$1.26.
- The company did not report any revenue for the quarter.